Sources: Stripe is aiming to raise ~$2.5B at a $55B to $60B valuation, led by Thrive Capital, which has committed $1B; Stripe was valued at ~$95B in March 2021
Thrive has committed $1 billion, which would value the payments provider Stripe at about $55 billion to $60 billion, people with knowledge of the matter said.
Context & Ripple Effects
Stripe's raise closes a loop that opened two years earlier: after early funding talks at $70B–$100B in late 2020 and a $115B print in secondary transactions by February 2021, the company peaked around $95B in March 2021 and is now raising primary capital at roughly half that mark. Thrive Capital's $1B lead commitment makes it the anchor buyer of the drawdown, not just a bystander.
The arc matters because the corpus shows what came next: Stripe recovered to $92B by February 2025, weighed a $140B+ tender offer a year later, and hit $159B through an employee share sale in which Thrive, Coatue, and a16z participated — meaning the investors who priced this down round were still holding through the recovery.
First-order effects
- Thrive converts $1B into a large Stripe position at a 35%–40% discount to the March 2021 mark, while Stripe banks $2.5B of primary capital without testing public markets.
- Employees whose option strikes were set against 2021-era secondaries near $95B are newly underwater on paper, resetting retention economics inside the company.
Second-order effects
- As the most-cited private fintech benchmark, Stripe's official re-mark forces every fund holding 2021-vintage payments stakes to mark its books lower, tightening new late-stage fintech pricing across the board.
- The insider-led structure — an existing backer committing early and setting the price — becomes the template other overvalued 2021 unicorns reach for when outside leads won't clear their old marks.
Third-order effects
- If the pattern holds, elite private companies cycle through down-round repricing and insider-funded recovery instead of going public to reset ownership, extending private-market duration and concentrating gains with funds patient enough to buy troughs — a structural win for concentrated frontier capital over retail access.
The trend: Late-stage tech is repricing through insider-led rounds and repeated secondary sales rather than IPOs, letting conviction investors like Thrive compound positions across full valuation cycles.